Constitution and quantity of lysis buffer alters outcome of reverse phase protein microarrays

Proteomics

Volumn 7, Issue 22, 2007, Pages 4066-4068

  Winters, Mary ^a   Dabir, Bhavana ^a   Yu, Minshu ^a   Kohn, Elise C ^a  

^a NATIONAL CANCER INSTITUTE   (United States)

Author keywords

Ovarian cancer; Protein extraction buffer; Reverse phase protein microarray

Indexed keywords

DITHIOTHREITOL;

ARTICLE; CELL LYSATE; HUMAN; HUMAN TISSUE; NEEDLE BIOPSY; OVARY CANCER; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN ISOLATION; PROTEIN MICROARRAY; PROTEOMICS;

BUFFERS; DITHIOTHREITOL; FEMALE; HUMANS; NEOPLASM PROTEINS; OVARIAN NEOPLASMS; PROTEIN ARRAY ANALYSIS; PROTEOMICS; REPRODUCIBILITY OF RESULTS; SODIUM DODECYL SULFATE; SOLUBILITY;

EID: 36549055581     PISSN: 16159853     EISSN: 16159861     Source Type: Journal    
DOI: 10.1002/pmic.200700484     Document Type: Article

References (15)

1. Speer, R., Wulfkuhle, J. D., Liotta, L. A., Petricoin, E. F., Reverse-phase protein microarrays for tissue-based analysis. Curr. Opin. Mol. Ther. 2005, 7, 240-245.
2. Paweletz, C. P., Charboneau, L., Bichsel, V. E., Simone, N. L. et al., Reverse phase protein microarrays which capture disease progression show activation of pro-survival pathways at the cancer invasion front. Oncogene 2001, 20, 1981-1989.
3. Winters, M. E., Mehta, A. I., Petricoin, E. F., III, Kohn, E. C., Liotta, L. A., Supra-additive growth inhibition by a celecoxib analogue and carboxyamido-triazole is primarily mediated through apoptosis. Cancer Res. 2005, 65, 3853-3860.
4. Wulfkuhle, J. D., Aquino, J. A., Calvert, V. S., Fishman, D. A. et al., Signal pathway profiling of ovarian cancer from human tissue specimens using reverse-phase protein microarrays. Proteomics 2003, 3, 2085-2090.
5. Gulmann, C., Espina, V., Petricoin, E., Longo, D. L. et al., Proteomic analysis of apoptotic pathways reveals prognostic factors in follicular lymphoma. Clin. Cancer Res. 2005, 11, 5847-5855.
6. Sheehan, K. M., Calvert, V. S., Kay, E. W., Lu, Y. L. et al., Use of reverse phase protein microarrays and reference standard development for molecular network analysis of metastatic ovarian carcinoma. Mol. Cell Proteomics 2005, 4, 346-355.
7. Nishizuka, S., Charboneau, L., Young, L., Major, S. et al., Proteomic profiling of the NCI-60 cancer cell lines using new high-density reverse-phase lysate microarrays. Proc. Natl. Acad. Sci. USA 2003, 100, 14229-14234.
8. de Marqui, A. B. T., Vidotto, A., Polachini, G. M., Bellato, C. D. et al., Solubilization of proteins from human lymph node tissue and two-dimensional gel storage. J. Biochem. Mol. Biol. 2006, 39, 216-222.
9. Tibes, R., Qiu, Y. H., Hennessy, B., Andreeff, M. et al., Reverse phase protein array: validation of a novel proteomic technology and utility for analysis of primary leukemia specimens and hematopoietic stem cells. Mol. Cancer Ther. 2006, 5, 2512-2521.
10. Posadas, E., Liel, M., Kwitkowsk, V., Minasian, L. et al., A phase II and pharmacodynamic study of gefitinib in patients with refactory or recurrent epithelial ovarian cancer. Cancer 2007, 109, 1323-1330.
11. Posadas, E. M., Kwitkowski, V., Kotz, H. L., Espina, V. et al., A prospective analysis of imatinib-induced c-KIT modulation in ovarian cancer: a phase II clinical study with proteomic profiling. Cancer 2007, 110, 309-317.
12. Ferguson, R., Carroll, H., Harris, A., Maher, E. et al., Housekeeping proteins: A preliminary study illustrating some limitations as useful references in protein expression studies. Proteomics 2005, 5, 566-571.
13. Dittmer, A., Dittmer, J., b-Actin is not a reliable loading control in Western blot analysis. Electrophoresis 2006, 27, 2844-2845.
14. Lee, P. D., Sladek, R., Greenwood, C. M. T., Hudson, T. J., Control genes and variability: Absence of ubiquitous reference transcripts in diverse mammalian expression studies. Genome Res. 2002, 12, 292-297.
15. Liu, N. K., Xu, X. M., beta-tubulin is a more suitable internal control than beta-actin in Western blot analysis of spinal cord tissues after traumatic injury. J. Neurotrauma 2006, 23, 1794-1801.